This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Roche Diagnostics Gmbh. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Thomas Zeibig - Innovator in Alkaline Phosphatase Detection
Introduction
Thomas Zeibig is a notable inventor based in Dannstadt-Schauernheim, Germany. He has made significant contributions to the field of biochemical detection, particularly in the area of alkaline phosphatase. His innovative work has led to the development of a stable mixture that enhances the detection process of this important enzyme.
Latest Patents
Thomas Zeibig holds a patent for a stable mixture for the detection of alkaline phosphatase. This invention includes the N-methylglucamine salt of o-cresolphthalein monophosphoric acid and N-methylglucamine, along with an analytical element designed for the detection of alkaline phosphatase. The method involves bringing a sample into contact with this mixture or analytical element, allowing for a color change to be observed in the presence of alkaline phosphatase. Additionally, his patent covers the production process of the salt of o-cresolphthalein monophosphoric acid with N-methylglucamine.
Career Highlights
Throughout his career, Thomas Zeibig has worked with prominent companies in the diagnostics field, including Roche Diagnostics GmbH and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise and innovation in biochemical detection technologies.
Collaborations
Thomas has collaborated with notable colleagues such as Rolf Nagel and Steffen Bossert-Reuther. These partnerships have likely fostered a creative environment that has led to advancements in their respective fields.
Conclusion
Thomas Zeibig's contributions to the detection of alkaline phosphatase through his innovative patent demonstrate his commitment to advancing biochemical analysis. His work continues to impact the field positively, showcasing the importance of innovation in scientific research.